Benefits
Enablement of Difficult-to-express Products
Zera® assembler peptides enable “difficult” proteins such as toxic-to-cell molecules (enzymes, other bioactive proteins), unstable or labile products (peptides, antimicrobials) and membrane proteins.
Versatility
Works in most eukaryotic cells lines with hormones, growth factors, peptides, enzymes, antigens, membrane proteins. Compatible with transient and stable transfection/transformation.
Simplification/acceleration downstream
Recovery by density delivers high pre-purification concentrations which are expected to result in significant operational cost-savings, size reduction in downstream cGMP suites, and overall faster process development.
Yield and quality gains upstream
A minimal 10-fold increase possible in protein yield on a per cell or biomass basis. In vivo encapsulation improves the capacity of the cell factory to assemble and accumulate complex products.
Novel drug/vaccine presentations
The unique structure of the StorPro® organelle matrix makes possible novel drug and vaccine formats which take advantage of the synthetic organelle’s physical properties.
|